HEADER VIRAL PROTEIN 22-JUN-23 8T8N TITLE VENEZUELAN EQUINE ENCEPHALITIS VIRUS (VEEV) NONSTRUCTURAL PROTEIN 2 TITLE 2 (NSP2) CYSTEINE PROTEASE INHIBITED WITH CA074 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE NSP2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NON-STRUCTURAL PROTEIN 2,NSP2; COMPND 5 EC: 3.4.22.-,3.6.1.15,3.6.1.74,3.6.4.13; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: CA074 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VENEZUELAN EQUINE ENCEPHALITIS VIRUS; SOURCE 3 ORGANISM_TAXID: 11036; SOURCE 4 STRAIN: TRINIDAD DONKEY; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: PLYSS KEYWDS CYSTEINE PROTEASE, CA074, ALPHAVIRUS, COVALENT, INHIBITOR, VIRAL KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.R.COMPTON,P.M.LEGLER REVDAT 1 09-AUG-23 8T8N 0 JRNL AUTH X.HU,E.MORAZZANI,J.R.COMPTON,M.HARMON,V.SOLOVEVA,P.J.GLASS, JRNL AUTH 2 A.D.GARCIA,J.J.MARUGAN,P.M.LEGLER JRNL TITL IN SILICO SCREENING OF INHIBITORS OF THE VENEZUELAN EQUINE JRNL TITL 2 ENCEPHALITIS VIRUS NONSTRUCTURAL PROTEIN 2 CYSTEINE JRNL TITL 3 PROTEASE. JRNL REF VIRUSES V. 15 2023 JRNL REFN ESSN 1999-4915 JRNL PMID 37515189 JRNL DOI 10.3390/V15071503 REMARK 2 REMARK 2 RESOLUTION. 2.32 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.32 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 51.19 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 14184 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.780 REMARK 3 FREE R VALUE TEST SET COUNT : 678 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.32 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 REFLECTION IN BIN (WORKING SET) : 952 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.21 REMARK 3 BIN R VALUE (WORKING SET) : 0.2230 REMARK 3 BIN FREE R VALUE SET COUNT : 50 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2551 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.60200 REMARK 3 B22 (A**2) : 0.72000 REMARK 3 B33 (A**2) : 0.88200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.474 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.217 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.139 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.689 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2672 ; 0.006 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2480 ; 0.003 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3631 ; 1.229 ; 1.663 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5748 ; 1.358 ; 1.594 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 325 ; 6.564 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 146 ;33.257 ;20.822 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 446 ;16.127 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;19.898 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 342 ; 0.060 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2993 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 590 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 499 ; 0.193 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 36 ; 0.170 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1278 ; 0.164 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 144 ; 0.171 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1288 ; 1.273 ; 1.981 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1287 ; 1.272 ; 1.979 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1611 ; 2.245 ; 2.964 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1612 ; 2.245 ; 2.967 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1384 ; 1.255 ; 2.215 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1385 ; 1.255 ; 2.217 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2018 ; 2.130 ; 3.237 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2019 ; 2.129 ; 3.238 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 8T8N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1000272924. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 150 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR-H REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : M REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER PLATINUM 135 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SADABS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14251 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.320 REMARK 200 RESOLUTION RANGE LOW (A) : 63.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 13.35 REMARK 200 R MERGE (I) : 0.13110 REMARK 200 R SYM (I) : 0.05080 REMARK 200 FOR THE DATA SET : 18.0300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.32 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.8 REMARK 200 DATA REDUNDANCY IN SHELL : 12.79 REMARK 200 R MERGE FOR SHELL (I) : 0.43570 REMARK 200 R SYM FOR SHELL (I) : 0.17170 REMARK 200 FOR SHELL : 6.080 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: PLATE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MODIFIED JCSG+ CONDITION 8 (0.2 M REMARK 280 AMMONIUM FORMATE, 20% W/V PEG3350, 20% GLYCEROL). PROTEIN BUFFER REMARK 280 CONTAINED 50 MM HEPES PH 7.0, 0.5 MM CA074, AND 30 MM CACL2, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.38100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.14150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.79100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.14150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.38100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.79100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 455 REMARK 465 SER A 456 REMARK 465 MET A 457 REMARK 465 ARG A 458 REMARK 465 HIS A 459 REMARK 465 ILE A 460 REMARK 465 LEU A 461 REMARK 465 GLU A 462 REMARK 465 ARG A 463 REMARK 465 PRO A 464 REMARK 465 ASP A 465 REMARK 465 PRO A 466 REMARK 465 THR A 467 REMARK 465 ARG A 788 REMARK 465 LEU A 789 REMARK 465 HIS A 790 REMARK 465 GLU A 791 REMARK 465 ALA A 792 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 472 30.87 70.52 REMARK 500 VAL A 476 40.91 -106.20 REMARK 500 ASN A 544 43.29 74.06 REMARK 500 PRO A 672 -161.38 -76.23 REMARK 500 ASN A 680 55.96 -96.50 REMARK 500 LYS A 686 -58.57 -125.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: [PROPYLAMINO-3-HYDROXY-BUTAN-1,4-DIONYL]-ISOLEUCYL- REMARK 630 PROLINE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 074 A 801 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 3CN LMR ILE PRO REMARK 630 DETAILS: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5EZS RELATED DB: PDB REMARK 900 E64D-INHIBITED NSP2 CYSTEINE PROTEASE DBREF 8T8N A 457 792 UNP P27282 POLN_EEVVT 992 1327 SEQADV 8T8N GLY A 455 UNP P27282 EXPRESSION TAG SEQADV 8T8N SER A 456 UNP P27282 EXPRESSION TAG SEQRES 1 A 338 GLY SER MET ARG HIS ILE LEU GLU ARG PRO ASP PRO THR SEQRES 2 A 338 ASP VAL PHE GLN ASN LYS ALA ASN VAL CYS TRP ALA LYS SEQRES 3 A 338 ALA LEU VAL PRO VAL LEU LYS THR ALA GLY ILE ASP MET SEQRES 4 A 338 THR THR GLU GLN TRP ASN THR VAL ASP TYR PHE GLU THR SEQRES 5 A 338 ASP LYS ALA HIS SER ALA GLU ILE VAL LEU ASN GLN LEU SEQRES 6 A 338 CYS VAL ARG PHE PHE GLY LEU ASP LEU ASP SER GLY LEU SEQRES 7 A 338 PHE SER ALA PRO THR VAL PRO LEU SER ILE ARG ASN ASN SEQRES 8 A 338 HIS TRP ASP ASN SER PRO SER PRO ASN MET TYR GLY LEU SEQRES 9 A 338 ASN LYS GLU VAL VAL ARG GLN LEU SER ARG ARG TYR PRO SEQRES 10 A 338 GLN LEU PRO ARG ALA VAL ALA THR GLY ARG VAL TYR ASP SEQRES 11 A 338 MET ASN THR GLY THR LEU ARG ASN TYR ASP PRO ARG ILE SEQRES 12 A 338 ASN LEU VAL PRO VAL ASN ARG ARG LEU PRO HIS ALA LEU SEQRES 13 A 338 VAL LEU HIS HIS ASN GLU HIS PRO GLN SER ASP PHE SER SEQRES 14 A 338 SER PHE VAL SER LYS LEU LYS GLY ARG THR VAL LEU VAL SEQRES 15 A 338 VAL GLY GLU LYS LEU SER VAL PRO GLY LYS MET VAL ASP SEQRES 16 A 338 TRP LEU SER ASP ARG PRO GLU ALA THR PHE ARG ALA ARG SEQRES 17 A 338 LEU ASP LEU GLY ILE PRO GLY ASP VAL PRO LYS TYR ASP SEQRES 18 A 338 ILE ILE PHE VAL ASN VAL ARG THR PRO TYR LYS TYR HIS SEQRES 19 A 338 HIS TYR GLN GLN CYS GLU ASP HIS ALA ILE LYS LEU SER SEQRES 20 A 338 MET LEU THR LYS LYS ALA CYS LEU HIS LEU ASN PRO GLY SEQRES 21 A 338 GLY THR CYS VAL SER ILE GLY TYR GLY TYR ALA ASP ARG SEQRES 22 A 338 ALA SER GLU SER ILE ILE GLY ALA ILE ALA ARG GLN PHE SEQRES 23 A 338 LYS PHE SER ARG VAL CYS LYS PRO LYS SER SER LEU GLU SEQRES 24 A 338 GLU THR GLU VAL LEU PHE VAL PHE ILE GLY TYR ASP ARG SEQRES 25 A 338 LYS ALA ARG THR HIS ASN PRO TYR LYS LEU SER SER THR SEQRES 26 A 338 LEU THR ASN ILE TYR THR GLY SER ARG LEU HIS GLU ALA HET 074 A 801 27 HETNAM 074 [PROPYLAMINO-3-HYDROXY-BUTAN-1,4-DIONYL]-ISOLEUCYL- HETNAM 2 074 PROLINE HETSYN 074 CA-074; [N-(L-3-TRANS-PROPYLCARBAMOYL-OXIRANE-2- HETSYN 2 074 CARBONYL)-L-ISOLEUCYL-L-PROLINE] FORMUL 2 074 C18 H31 N3 O6 FORMUL 3 HOH *135(H2 O) HELIX 1 AA1 VAL A 476 THR A 488 1 13 HELIX 2 AA2 THR A 494 ASN A 499 1 6 HELIX 3 AA3 VAL A 501 THR A 506 1 6 HELIX 4 AA4 SER A 511 GLY A 525 1 15 HELIX 5 AA5 ASP A 527 GLY A 531 5 5 HELIX 6 AA6 ASN A 559 ARG A 568 1 10 HELIX 7 AA7 GLN A 572 GLY A 580 1 9 HELIX 8 AA8 PHE A 622 LYS A 628 1 7 HELIX 9 AA9 ARG A 662 GLY A 666 5 5 HELIX 10 AB1 HIS A 688 LEU A 703 1 16 HELIX 11 AB2 LYS A 705 LEU A 709 5 5 HELIX 12 AB3 ASP A 726 ARG A 738 1 13 HELIX 13 AB4 PRO A 773 GLY A 786 1 14 SHEET 1 AA1 2 VAL A 538 PRO A 539 0 SHEET 2 AA1 2 MET A 555 TYR A 556 -1 O TYR A 556 N VAL A 538 SHEET 1 AA2 2 SER A 541 ILE A 542 0 SHEET 2 AA2 2 TRP A 547 ASP A 548 -1 O ASP A 548 N SER A 541 SHEET 1 AA3 2 VAL A 582 TYR A 583 0 SHEET 2 AA3 2 LEU A 590 ARG A 591 -1 O ARG A 591 N VAL A 582 SHEET 1 AA4 7 PHE A 659 ARG A 660 0 SHEET 2 AA4 7 MET A 647 SER A 652 1 N TRP A 650 O PHE A 659 SHEET 3 AA4 7 THR A 633 GLY A 638 1 N VAL A 634 O MET A 647 SHEET 4 AA4 7 TYR A 674 ASN A 680 1 O PHE A 678 N VAL A 637 SHEET 5 AA4 7 LEU A 711 GLY A 721 1 O THR A 716 N ASP A 675 SHEET 6 AA4 7 VAL A 757 TYR A 764 -1 O TYR A 764 N GLY A 714 SHEET 7 AA4 7 PHE A 740 CYS A 746 -1 N CYS A 746 O LEU A 758 LINK SG CYS A 477 C6 074 A 801 1555 1555 1.82 CRYST1 60.762 63.582 86.283 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016458 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015728 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011590 0.00000